Sightera Biosciences is a Belgian techbio company using generative AI to develop novel small-molecule therapies.
Sightera Biosciences has raised €3.0M across 1 funding round from 3 investors, most recently a Pre-Seed round in Jul 2026. Based in Antwerp, Belgium; active in Healthtech. Data as of 17 Jul 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-17 | Pre-Seed | €3.0M |
| Anacura,Entourage ,Qbic |
| View deal → |
